Integrating radiotherapy with epidermal growth factor receptor antagonists and other molecular therapeutics for the treatment of head and neck cancer

被引：35

作者：

Thariat, Juliette

Milas, Luka

Ang, K. Kian

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA

[2] Univ Texas, MD Anderson Canc Ctr, Dept Expt Radiol Oncol, Houston, TX 77030 USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 69卷 / 04期

关键词：

D O I：

10.1016/j.ijrobp.2007.06.076

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：974 / 984

页数：11

共 74 条

[51] Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: A pilot phase II study of a new combined-modality paradigm [J].

Pfister, DG ;

Su, YB ;

Kraus, DH ;

Wolden, SL ;

Lis, E ;

Aliff, TB ;

Zahalsky, AJ ;

Lake, S ;

Needle, MN ;

Shaha, AR ;

Shah, JP ;

Zelefsky, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1072-1078

[52] Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis [J].

Psyrri, A ;

Yu, ZW ;

Weinberger, PM ;

Sasaki, C ;

Haffty, B ;

Camp, R ;

Rimm, D ;

Burtness, BA .

CLINICAL CANCER RESEARCH, 2005, 11 (16) :5856-5862

[53] Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: A randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02) [J].

Rischin, D ;

Peters, L ;

Fisher, R ;

Macann, A ;

Denham, J ;

Poulsen, M ;

Jackson, M ;

Kenny, L ;

Penniment, M ;

Corry, J ;

Lamb, D ;

McClure, B .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) :79-87

[54] Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer [J].

Robert, F ;

Ezekiel, MP ;

Spencer, SA ;

Meredith, RF ;

Bonner, JA ;

Khazaeli, MB ;

Saleh, MN ;

Carey, D ;

LoBuglio, AF ;

Wheeler, RH ;

Cooper, MR ;

Waksal, HW .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) :3234-3243

[55] Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation [J].

Saleh, MN ;

Raisch, KP ;

Stackhouse, MA ;

Grizzle, WE ;

Bonner, JA ;

Mayo, MS ;

Kim, HG ;

Meredith, RF ;

Wheeler, RH ;

Buchsbaum, DJ .

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1999, 14 (06) :451-463

[56]

Sato J D, 1983, Mol Biol Med, V1, P511

[57] Cell Signaling by Receptor Tyrosine Kinases [J].

Lemmon, Mark A. ;

Schlessinger, Joseph .

CELL, 2010, 141 (07) :1117-1134

[58] ERBB receptor tyrosine kinases and cellular radiation responses [J].

Schmidt-Ullrich, RK ;

Contessa, JN ;

Lammering, G ;

Amorino, G ;

Lin, PS .

ONCOGENE, 2003, 22 (37) :5855-5865

[59] Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation [J].

SchmidtUllrich, RK ;

Mikkelsen, RB ;

Dent, P ;

Todd, DG ;

Valerie, K ;

Kavanagh, BD ;

Contessa, JN ;

Rorrer, WK ;

Chen, PB .

ONCOGENE, 1997, 15 (10) :1191-1197

[60] ALTERED EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND ESTROGEN-RECEPTOR IN MCF-7 CELLS AFTER SINGLE AND REPEATED RADIATION EXPOSURES [J].

SCHMIDTULLRICH, RK ;

VALERIE, KC ;

CHAN, W ;

MCWILLIAMS, D .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (04) :813-819

← 1 2 3 4 5 6 7 8 →